Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Pegylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody

EU orphan designation number: EU/3/13/1178
Active ingredient: Pegylated recombinant anti-Pseudomonas aeruginosa PcrV Fab′ antibody
Indication: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Sponsor: KaloBios Ltd
5 Fleet Place, London EC4M 7RD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan designation EMA/OD/073/13 (2013)5277 of 05/08/2013
30/01/2015 Removal of orphan designation from Community Register